HOME >> BIOLOGY >> NEWS
Gene vital to radiation resistance in bacteria

NEW ORLEANS January 31, 2003 -- Researchers from Louisiana State University have identified a gene in the radiation-resistant bacterium Deinococcus radiodurans that they believe is vital to the organism's ability to withstand high levels of radiation. They report their findings today at the 3rd ASM/TIGR Conference on Microbial Genomes.

"When this gene (irrE) is not functional you have a very sensitive organism," says Ashlee Earl, a lead researcher on the study. "At a dose of radiation that would not normally kill D. radiodurans, there is less than .001 percent survival without irrE."

With a name that literally means "strange berry that can withstand radiation," D. radiodurans is the world's most radiation resistant organism, able to survive up to 1.5 million rads, over 1000 times more radiation than practically any other organism. For reference, 1000 rads is enough to kill the average human.

For decades scientists have been trying to figure out what makes it so hard to kill. Understanding how this bacterium survives such extreme conditions could help researchers with everything from cleaning up nuclear waste sites to preventing cancer.

To better define the mechanisms used by the bacterium to resist radiation, Earl and her team, which included researchers from The Institute for Genomic Research (TIGR), studied a mutant strain of D. radiodurans that could not survive high radiation levels. This strain carried mutations on two genes, one of which was irrE. When the irrE gene was restored, the bacterium was once again resistant to radiation, a finding that suggested the gene was responsible, at least in some part, for resistance.

Further study of irrE suggested that the gene is not directly responsible for DNA repair following radiation exposure but instead it controls other genes that are known in other organisms to be associated with DNA repair. It's role is also not specific to radiation. The gene is responsible in some part for D.
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
31-Jan-2003


Page: 1 2

Related biology news :

1. Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds
2. Education, monitoring vital for sport-fish eaters
3. Life goes on without vital DNA
4. Rb2 expression could play vital role in ovarian cancer Temple University researchers find
5. Vascular access vital to pump up tissue engineering
6. Study links amyloid plaques in Alzheimers brains to genes vital to normal memory
7. Family communication about hereditary disease vital to prevention
8. St. Jude researchers show that the Six3 gene is vital in the creation of the brains complexity
9. Wheat may be vital in battle against cancer and other diseases
10. Researchers describe atomic-size sorter that performs vital cellular function
11. Stem cell research is vital to finding cures for blinding diseases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene vital radiation resistance bacteria

(Date:8/26/2015)... The report "Multi-Factor Authentication (MFA) Market ... (Travel & Immigration, Government, Banking, Defense, Commercial Security, Consumer ... published by MarketsandMarkets, Multi-Factor Authentication Market is expected to ... CAGR of 17.7% between 2015 and 2020. ... spread through 169 P ages and ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a global ... and manufacture of highly valued cardiac markers used in early detection of heart ... protein chemistry has led to the development and commercialization of important cardiac biomarkers ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 ... Scene with Impressive Acheivements  DiaCardio wins 1 st ... The competition, led in Israel ... featured 21 startups from countries including the US, China ... and Latin America .  Impressive ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
Cached News: